Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer

BACKGROUND: The objective of this study was to discover and to validate novel noninvasive biomarkers that distinguish between benign prostate hyperplasia (BPH) and localized prostate cancer (PCa), thereby helping to solve the diagnostic dilemma confronting clinicians who treat these patients. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Jedinak, Andrej, Curatolo, Adam, Zurakowski, David, Dillon, Simon, Bhasin, Manoj K, Libermann, Towia A, Roy, Roopali, Sachdev, Monisha, Loughlin, Kevin R, Moses, Marsha A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433087/
https://www.ncbi.nlm.nih.gov/pubmed/25884438
http://dx.doi.org/10.1186/s12885-015-1284-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433087/
https://www.ncbi.nlm.nih.gov/pubmed/25884438
http://dx.doi.org/10.1186/s12885-015-1284-z

Ejemplares similares